Literature DB >> 12024334

Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion.

Prediman K Shah1.   

Abstract

Coronary artery disease is the leading cause of death in much of the western world. Atherosclerotic plaques in the coronary arteries contribute to luminal obstruction leading to myocardial ischemia; however, abrupt coronary artery occlusion most frequently results from superimposition of a thrombus on a disrupted plaque, leading to the most serious clinical manifestations of coronary artery disease, ie, unstable angina, acute myocardial infarction, and sudden death. Plaque that have undergone disruption and, by inference, plaques at risk for disruption (vulnerable plaques), tend to demonstrate outward vessel remodeling, contain a large lipid core, thinned out fibrous cap, reduced collagen content, and increased inflammatory cell infiltration. Plaque stabilization through change in plaque composition may be responsible for reduced frequency of acute vaso-occlusive events observed with lipid and other risk-factor modifying interventions. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12024334     DOI: 10.1053/pcad.2002.123473

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  17 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

2.  Low CPNE3 expression is associated with risk of acute myocardial infarction: A feasible genetic marker of acute myocardial infarction in patients with stable coronary artery disease.

Authors:  Buchuan Tan; Long Liu; Yushuang Yang; Qian Liu; Liping Yang; Fanbo Meng
Journal:  Cardiol J       Date:  2018-01-03       Impact factor: 2.737

3.  Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.

Authors:  Shen Li; Yan-Ning Wang; Manabu Niimi; Bo Ning; Yajie Chen; Dedong Kang; Ziyun Wang; Qi Yu; Ahmed Bilal Waqar; Enqi Liu; Jifeng Zhang; Masashi Shiomi; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-17       Impact factor: 8.311

Review 4.  MRI of atherosclerosis: diagnosis and monitoring therapy.

Authors:  Christopher M Kramer; Justin D Anderson
Journal:  Expert Rev Cardiovasc Ther       Date:  2007-01

5.  Ultrastructural changes in atherosclerotic plaques following the instillation of airborne particulate matter into the lungs of rabbits.

Authors:  Erin M Tranfield; Stephan F van Eeden; Kazuhiro Yatera; James C Hogg; David C Walker
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

6.  Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.

Authors:  David E Sosnovik; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-04-01

7.  3D MRI-based anisotropic FSI models with cyclic bending for human coronary atherosclerotic plaque mechanical analysis.

Authors:  Dalin Tang; Chun Yang; Shunichi Kobayashi; Jie Zheng; Pamela K Woodard; Zhongzhao Teng; Kristen Billiar; Richard Bach; David N Ku
Journal:  J Biomech Eng       Date:  2009-06       Impact factor: 2.097

8.  Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.

Authors:  Li Lu; Hong Liu; Jiahe Peng; Lin Gan; Lili Shen; Qian Zhang; Liangpeng Li; Li Zhang; Chang Su; Yu Jiang
Journal:  Lipids Health Dis       Date:  2010-02-06       Impact factor: 3.876

9.  Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.

Authors:  Alexander B Sigalov
Journal:  Contrast Media Mol Imaging       Date:  2014-04-14       Impact factor: 3.161

10.  Antiplatelet drugs and the perioperative period: What every urologist needs to know.

Authors:  Pawan Vasudeva; Apul Goel; Vengetesh K Sengottayan; Satyanarayan Sankhwar; Divakar Dalela
Journal:  Indian J Urol       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.